background
diabet
mellitu
morbid
mortal
cardiovascular
diseas
increas
repres
import
independ
mechan
heart
diseas
exacerb
pathogenesi
diabet
cardiomyopathi
involv
enhanc
activ
ppar
transcript
factor
includ
lesser
degre
transcript
factor
regul
heart
larg
unknown
recent
studi
describ
posttransl
ubiquitin
ppar
way
ppar
activ
inhibit
cancer
howev
specif
mechan
heart
previous
describ
recent
studi
implic
musclespecif
ubiquitin
ligas
muscl
ring
inhibit
nuclear
transcript
factor
srf
initi
studi
heart
reveal
enhanc
ppar
activ
lead
hypothesi
regul
ppar
activ
posttransl
ubiquitin
method
mice
challeng
fat
diet
design
simul
obesitymedi
insulin
resist
diabet
cardiomyopathi
mice
follow
consciou
echocardiographi
blood
glucos
tissu
triglycerid
glycogen
level
immunoblot
analysi
intracellular
signal
heart
skelet
muscl
morphometr
mrna
express
lead
caus
morbid
mortal
worldwid
cardiovascular
diseas
frequent
accompani
dysregul
fatti
acid
metabol
associ
diabet
mellitu
dm
presenc
dm
morbid
mortal
cardiovascular
diseas
increas
repres
import
independ
mechan
heart
diseas
exacerb
characterist
disturb
myocardi
energi
fatti
acid
homeostasi
found
dm
mediat
primarili
network
peroxisom
proliferatoractiv
receptor
ppar
transcript
factor
direct
energi
substrat
determin
myocardi
homeostasi
chronic
activ
ppar
dm
lead
increas
free
fatti
acid
uptakeoxid
correspond
level
insulin
resist
cardiomyocyt
increas
relianc
fatti
acid
metabol
decreas
effici
heart
increas
amount
oxygen
need
creat
need
energi
result
lipotox
ligand
fatti
acid
driven
activ
ppar
transcript
factor
regul
express
target
gene
control
uptak
util
oxid
storag
fatti
acid
heart
three
ppar
receptor
identifi
implic
cardiovascular
diseas
insulin
resist
risk
factor
left
ventricular
lv
dysfunct
heart
failur
one
hallmark
type
dm
despit
hyperinsulinemia
hyperglycemia
diabet
heart
reli
almost
exclus
fatti
acid
util
rodent
model
human
excess
fat
intak
result
increas
fatti
acid
increas
reaction
oxygen
speci
ro
product
accumul
lipid
intermedi
eg
diacylglycerol
dag
profound
impact
insulin
signal
cjun
nh
kinas
jnk
inhibitor
kinas
ikk
activ
ro
parallel
activ
protein
kinas
c
pkc
dag
act
downregul
insulin
action
prevent
insulin
receptor
phosphoryl
high
system
fatti
acid
uptak
also
inhibit
akt
signal
result
downregul
forkhead
box
foxo
transcript
factor
increas
ro
activ
nuclear
factor
kappa
b
contribut
develop
cardiac
hypertrophi
muscl
ring
finger
murf
famili
ubiquitin
ligas
includ
identifi
highli
homolog
group
protein
homoand
heterodimer
coiledcoil
domain
famili
protein
found
striat
muscl
includ
skelet
cardiac
myocyt
origin
found
critic
regul
microtubul
assembl
model
skelet
muscl
develop
recent
studi
detail
import
earliest
stage
skelet
muscl
differenti
myofibrillogenesi
vivo
present
studi
identifi
endogen
cardiomyocyt
inhibit
multipl
ppar
isoform
primarili
lesser
extent
given
rel
import
ppar
develop
diabet
cardiomyopathi
downstream
pathophysiolog
challeng
mice
fat
dietinduc
cardiomyopathi
recent
describ
ppar
signal
center
regul
fatti
acid
oxid
mediat
pathogenesi
type
dm
induc
cardiomyopathi
hypothes
heart
enhanc
ppar
signal
would
undergo
acceler
cardiomyopathi
due
direct
regul
ppar
activ
identifi
heart
undergo
exagger
diabet
cardiomyopathi
result
multiubiquitin
proteasomeindepend
nondegradatori
mechan
studi
identifi
first
ubiquitin
ligas
regul
ppar
via
posttransl
ubiquitin
experi
describ
use
agematch
mice
litterm
male
femal
experi
approv
institut
anim
care
use
committe
iacuc
review
board
univers
north
carolina
perform
accord
feder
guidelin
ten
weekold
strainmatch
wild
type
mice
fed
high
fat
diet
fat
protein
carbohydr
week
previous
describ
baselin
bodi
weight
blood
glucos
serum
insulin
serum
triglycerid
total
cholesterol
level
along
cardiac
function
obtain
prior
start
diet
bodi
weight
blood
glucos
serum
insulin
level
measur
everi
week
echocardiographi
perform
everi
week
mri
perform
baselin
week
detect
bodi
composit
chang
week
mice
anesthet
isofluran
euthan
cervic
spine
disloc
heart
liver
gastrocnemiu
soleu
tibiali
anterior
muscl
collect
cryovial
flash
frozen
store
fatti
acid
extract
tissu
triglycerid
concentr
determin
flash
frozen
heart
tissu
liver
tissu
skelet
tissu
previous
describ
briefli
mg
heart
liver
skelet
muscl
homogen
blade
homogen
power
gen
cat
set
fisher
scientif
inc
pittsburgh
pa
usa
vw
ice
cold
lysi
buffer
mm
tri
base
mm
nacl
mm
naf
mm
tablet
proteas
inhibitor
roch
inc
cat
incub
h
two
hundr
microlit
homogen
transfer
chloroform
resist
tube
mix
ml
methanol
ml
chloroform
place
rocker
least
min
potassium
chlorid
ml
kcl
ad
sampl
vortex
centrifug
min
bottom
layer
chcl
transfer
process
repeat
anoth
ml
chloroform
combin
chcl
layer
dri
n
one
hundr
microlit
tertbutanol
methanol
triton
solut
vvv
ad
tube
sampl
store
glycerol
standard
mgdl
sigma
inc
cat
free
glycerol
reagent
sigma
aldrich
inc
cat
triglycerid
reagent
sigma
aldrich
inc
cat
use
measur
triglycerid
concentr
five
microlit
sampl
ad
plate
work
reagent
ad
sampl
four
volum
free
glycerol
reagent
volum
triglycerid
reagent
left
incub
rock
room
temperatur
min
absorb
measur
per
sampl
nm
use
clariostar
high
perform
multimod
micropl
reader
bmg
labtech
san
francisco
ca
usa
normal
tissu
weight
tissu
glycogen
measur
heart
liver
skelet
muscl
use
colorimetr
tissu
glycogen
assay
kit
sigma
inc
cat
previous
describ
briefli
mg
tissu
powder
liquid
nitrogen
collect
prechil
ml
tube
ml
n
hcl
ad
homogen
blade
homogen
fisher
scientif
power
gen
cat
set
pittsburgh
pa
usa
hood
result
homogen
quickli
ad
n
naoh
kept
ice
heat
hcl
min
mix
everi
min
cool
rt
ml
n
na
oh
ad
neutral
sampl
sampl
centrifug
min
rt
supernat
use
glucos
analysi
use
hexokinasedepend
assay
kit
sigma
inc
cat
accord
manufactur
instruct
briefli
liver
heart
gastrocnemiu
supernat
put
plate
mix
reagent
incub
room
temperatur
min
absorb
measur
nm
cell
cultur
dmem
contain
fb
unitml
penicillin
mg
ml
streptomycin
cardiomyocyt
cultur
supplement
claycomb
medium
contain
fb
unitml
penicillin
mgml
streptomycin
mm
norepinephrin
mm
lglutamin
cell
incub
co
humidifi
atmospher
cardiomyocyt
confluent
plate
gelatinfibronectin
cotransfect
use
lipofectamin
ltx
plu
invitrogen
lot
accord
manufactur
instruct
ratio
ltxdna
plusdna
equal
amount
dna
transfect
adjust
empti
vector
h
transfect
cell
fix
paraformaldehyd
block
goat
serum
room
temperatur
h
cell
incub
rb
antiflag
sigma
overnight
ms
antiha
sigma
overnight
cell
wash
incub
antim
detect
invitrogen
anti
rb
invitrogen
h
room
temperatur
membran
cut
cm
section
mount
glass
slide
fluorogel
antifad
mount
medium
dapi
em
hatfield
pa
cat
analyz
fluoresc
confoc
microscopi
use
zeiss
clsm
spectral
confoc
laser
scan
microscop
total
rna
isol
use
trizol
reagent
accord
manufactur
protocol
life
technolog
inc
cat
approxim
mg
cardiac
ventricular
tissu
put
trizol
reagent
homogen
ice
fisher
scientif
power
gen
set
total
mrna
express
determin
use
twostep
reaction
cdna
made
total
rna
use
iscript
revers
transcript
supermix
rtqpcr
kit
cat
biorad
total
volum
per
reaction
complet
reaction
mix
incub
eppendorf
cycler
hamburg
germani
use
follow
protocol
prime
min
revers
transcript
min
rt
inactiv
min
pcr
product
amplifi
roch
lightcycl
system
use
cdna
taqman
probe
appli
bioscienc
lightcycl
probe
master
mix
cat
taqman
probe
use
studi
adrp
anp
bnp
sk
appli
biosystem
inc
foster
citi
ca
usa
assay
perform
use
roch
univers
probe
technolog
includ
forward
primer
gggctgaggagaagtcacac
revers
primer
gggctgaggagaagtcacac
conjunct
upl
probe
roch
inc
cat
sampl
run
triplic
rel
mrna
express
determin
use
intern
endogen
control
rnasefre
water
master
mix
taqman
probe
roch
upl
primer
probe
cdna
use
reaction
western
analysi
ventricular
tissu
perform
lysat
creat
mg
tissu
place
cell
signal
lysi
buffer
ml
ml
cell
signal
lysi
buffer
cat
g
phosphat
sigma
cat
tablet
proteas
inhibitor
roch
cat
phosphatas
inhibitor
cocktail
roch
cat
homogen
ice
fisher
scientif
power
gen
set
homogen
incub
ice
min
centrifug
min
supernat
store
protein
concentr
determin
use
biorad
dc
protein
assay
reagent
packag
biorad
laboratori
inc
hercul
ca
cat
protein
resolv
nupag
bistri
trisacet
well
gel
mous
rabbit
rabbit
use
measur
signal
cell
signal
technolog
cat
signal
detect
use
rabbit
rabbit
cell
signal
technolog
inc
cat
cjun
signal
detect
rabbit
antipcjun
rb
antipcjun
rb
anticjun
cell
signal
technolog
cat
rabbit
abcam
inc
cat
rabbit
abcam
inc
cat
rabbit
cell
signal
technolog
inc
cat
use
measur
protein
express
ppar
isoform
protein
express
detect
goat
abcam
inc
cat
primari
antibodi
dilut
milk
bovin
serum
albumin
incub
overnight
hrplabel
secondari
antibodi
mous
sigma
goat
sigma
rabbit
sigma
use
detect
primari
antibodi
dilut
tbst
incub
h
room
temperatur
mous
sigma
inc
cat
mous
antigapdh
sigma
inc
cat
use
load
control
throughout
secondari
antibodi
hrp
detect
use
ecl
select
ge
healthcar
cat
imag
use
multidocit
imag
system
uvp
llc
ultraviolet
product
ltd
upland
ca
usa
cell
cotransfect
dna
plasmid
h
transfect
cell
lyse
use
ripa
buffer
sigma
inc
cat
protein
concentr
determin
use
biorad
dc
protein
assay
ezview
red
antiflag
affin
gel
bead
sigma
inc
cat
wash
twice
use
tb
addit
protein
lysat
sampl
gentli
agit
roller
shaker
overnight
three
wash
protein
elut
ld
sampl
buffer
nupag
ld
sampl
buffer
lot
boil
min
sampl
analyz
immunoblot
total
oglcnac
express
determin
sdspage
previous
describ
use
antioglcnac
santa
cruz
biotechnolog
santa
cruz
ca
pvdf
block
bovin
serum
albumin
dissolv
tbst
solut
min
follow
overnight
incub
oglcnac
antibodi
secondari
antibodi
goatantimous
igghrp
santa
cruz
biotechnolog
santa
cruz
ca
incub
h
room
temperatur
wash
tbst
visual
enhanc
chemiluminesc
ecl
chemidoc
xr
system
imag
lab
softwar
biorad
laboratori
hercul
ca
usa
total
oglcnacyl
per
lane
quantifi
adjust
percentag
volumeintens
unit
pixel
band
mm
background
subtract
use
quantiti
one
softwar
biorad
laboratori
hercul
ca
usa
normal
abcam
cambridg
usa
cardiac
tissu
flash
frozen
liquid
nitrogen
cool
biopress
fraction
weigh
mg
weight
fine
ground
ad
fresh
acetylnitril
water
formic
acid
standard
concentr
mcl
buffer
fulli
homogen
ice
place
dri
ice
store
sampl
crash
deproton
methanol
precipit
spike
myrist
acid
intern
standard
retentiontim
lock
dri
trimethylsilyl
tm
standard
retent
time
rt
set
min
reactiv
carbonyl
stabil
methoxyamin
hydrochlorid
dri
pyridin
metabolit
made
volatil
tm
group
use
nmethyln
trimethylsilyl
trifluoroacetamid
mstfa
catalyt
trimethylchlorosilan
gcm
method
gener
follow
roessner
et
al
fiehn
et
al
kind
et
al
use
n
gc
connect
inert
singl
quadrupol
ms
agil
technolog
santa
clara
ca
usa
two
wallcoat
opentubular
wcot
gc
column
connect
seri
j
w
agil
part
length
mm
diamet
lumin
film
posit
ion
gener
convent
electronion
ei
ev
scan
broadli
mz
detector
throughout
min
cycl
time
data
acquir
analyz
previous
describ
sigma
plot
prism
use
plot
statist
analyz
data
depend
upon
experiment
design
sever
statist
test
appli
studi
student
test
one
way
anova
follow
holmsidak
pairwis
post
hoc
analysi
perform
indic
figur
legend
signific
determin
p
valu
express
mean
se
statist
analysi
metabolom
data
perform
previous
describ
metaboanalyst
run
statist
packag
r
use
metabolit
peak
area
repres
concentr
data
first
analyz
unsupervis
princip
compon
analysi
pca
identifi
presenc
week
high
fat
diet
princip
sourc
varianc
sharpen
separ
three
group
data
next
analyz
use
partial
least
squar
discrimin
analysi
plsda
determin
metabolit
respons
separ
two
group
specif
metabolit
contribut
significantli
differ
identifi
plsda
wildtyp
control
group
heart
determin
use
variabl
import
project
vip
analysi
metaboanalyst
environ
metabolit
best
differenti
group
individu
test
use
student
ttest
microsoft
excel
seattl
wa
usa
vip
test
signific
metabolit
match
metabolom
pathway
use
pathway
analysi
featur
metaboanalyst
heat
map
metabolit
data
individu
group
gener
use
gene
e
softwar
http
wwwbroadinstitut
orgcancersoftwaregeneeindexhtml
recent
identifi
musclespecif
ubiquitin
ligas
critic
factor
regul
cardiomyocyt
size
develop
concert
also
describ
effector
protein
complex
respond
mechan
chang
sarcomer
inhibit
transactiv
nuclear
transcript
factor
serum
respons
factor
srf
regul
nuclear
specif
srf
first
indic
found
primarili
cytoplasm
could
regul
activ
nuclear
receptor
presum
direct
interact
ubiquitin
appar
nuclear
export
find
led
us
hypothes
similarli
regul
nuclear
receptor
critic
cardiomyocyt
test
use
mice
previous
character
without
cardiac
skelet
muscl
phenotyp
howev
recent
identifi
heart
exhibit
chang
metabolom
signatur
indic
chang
metabol
present
despit
function
effect
baselin
initi
assay
isol
nuclei
heart
dnabind
activ
contribut
ppar
best
describ
alter
cardiac
metabol
report
regul
ubiquitin
surpris
found
heart
significantli
increas
ppar
activ
increas
twofold
fold
fourfold
activ
compar
sibl
control
mice
fig
find
suggest
endogen
attenu
activ
three
ppar
transcript
factor
found
cardiomyocyt
sinc
ubiquitin
ligas
ppar
transcript
factor
describ
posttransl
modif
ubiquitin
hypothes
may
regul
ppar
transcript
factor
ubiquitinationdepend
manner
pathogenesi
diabet
cardiomyopathi
involv
enhanc
activ
ppar
transcript
factor
diabet
cardiomyopathi
character
increas
free
fatti
acid
oxid
parallel
cardiomyocyt
insulin
resist
result
increas
fatti
acid
oxid
insulin
contribut
decreas
abil
heart
switch
away
fatti
acid
util
glucos
sinc
cardiac
mice
exhibit
enhanc
ppar
activ
hypothes
induct
diabet
cardiomyopathi
would
result
enhanc
ppar
activ
result
signific
cardiac
dysfunct
compar
wildtyp
mice
test
hypothesi
challeng
mice
highfat
diet
reproduc
induc
insulin
resist
diabet
cardiomyopathi
fig
week
high
fat
diet
challeng
mice
significantli
lower
blood
glucos
compar
sibl
wildtyp
control
differ
serum
insulin
level
addit
file
figur
serum
triglycerid
similarli
elev
wildtyp
control
week
high
fat
diet
addit
file
figur
increas
cardiac
protein
level
identifi
high
fat
diet
fig
parallel
increas
identifi
human
inflammatori
dilat
cardiomyopathi
http
coronari
arteri
atherosclerosi
http
heart
increas
total
weight
wildtyp
control
high
fat
diet
challeng
fig
addit
signific
increas
overal
bodi
weight
week
hfd
fig
howev
signific
chang
identifi
gastrocnemiu
soleu
tibiali
anterior
muscl
weight
addit
file
figur
echocardiograph
analysi
heart
baselin
found
deficit
function
differ
measur
fig
tabl
previous
describ
signific
deficit
heart
function
identifi
heart
littl
week
initi
high
fat
diet
fig
wildtyp
mice
experienc
equal
progress
dilat
time
high
fat
diet
evidenc
increas
lvesd
fig
far
right
panel
heart
exhibit
signific
dysfunct
earli
week
hfd
compar
heart
fig
heart
significantli
larger
heart
week
high
fat
diet
fig
diabet
cardiomyocyterel
chang
myosin
heavi
chain
gene
express
next
investig
determin
differ
group
compar
increas
seen
wildtyp
heart
fig
consist
previou
studi
identifi
increas
cardiac
express
skelet
muscl
increas
chow
control
heart
compar
wild
type
mice
skelet
muscl
significantli
increas
compar
wild
type
mice
week
high
fat
diet
fig
differ
exist
week
high
fat
diet
either
mice
fig
although
report
model
diabet
cardiomyopathi
brain
natriuret
protein
bnp
mrna
decreas
control
week
high
fat
diet
feed
fig
taken
togeth
studi
identifi
heart
fail
sooner
heart
result
larger
heart
includ
lv
wall
thick
heart
weight
week
high
fat
diet
challeng
lv
remodel
distinct
find
pathogenesi
diabet
cardiomyopathi
chang
includ
develop
fibrosi
result
accumul
extracellular
collagen
reduc
activ
oglcnacyl
stimul
cardiac
fibroblast
collagen
synthesi
report
particular
model
less
fibrosi
identifi
throughout
heart
wildtyp
control
fig
howev
heart
reveal
parallel
reduct
vimentinposit
fibroblast
fig
week
high
fat
diet
wildtyp
mous
interestingli
reveal
almost
fibrosi
addit
file
figur
amorph
waxi
infiltr
leukocyt
infiltr
addit
file
figur
seen
either
wildtyp
heart
week
high
fat
diet
addit
file
figur
overal
heart
signific
increas
fibrosi
total
fibrosi
minim
account
larg
chang
cardiac
size
dysfunct
suggest
nonstructur
signal
pathway
like
involv
exagger
cardiac
dysfunct
diabet
cardiomyopathi
cardiac
pivot
role
pathophysiolog
diabet
cardiomyopathi
therefor
next
investig
express
cardiac
ppar
isoform
regul
gene
previous
describ
vivo
gene
express
cardiac
target
gene
regul
cardiac
ie
fig
cardiac
target
gene
associ
glucos
metabol
regul
cardiac
ie
pfk
mcad
lcad
fig
c
cardiac
cardiac
gene
ie
adrp
fig
evalu
mous
heart
notabl
heart
challeng
high
fat
diet
exhibit
significantli
increas
level
gene
fig
gene
associ
fatti
acid
metabol
fig
gene
fig
signific
observ
differ
group
mean
valu
determin
use
one
way
anova
follow
holmsidak
pairwis
post
hoc
analysi
n
per
group
indic
graph
p
p
p
heart
differ
heart
target
gene
associ
glucos
metabol
pfk
fig
like
ppar
isoform
activ
assay
heart
nuclei
demonstr
heart
exhibit
enhanc
ppar
activ
mrna
level
heart
exhibit
signific
increas
compar
wildtyp
mice
differ
addit
file
figur
fatti
acid
primari
fuel
heart
addit
ligand
ppar
transcript
factor
high
fat
diet
report
increas
cardiac
triglycerid
content
increas
storag
fat
myocardi
triglycerid
occur
develop
type
diabet
cardiomyopathi
hypothes
one
mechan
free
fatti
acid
toxic
heart
mishandl
cardiac
glycogen
also
frequent
manifest
diabet
cardiomyopathi
hypothes
increas
level
fatti
acid
heart
could
contribut
enhanc
heart
failur
demonstr
diabet
cardiomyopathi
sinc
report
heart
skelet
muscl
addit
liver
measur
cardiac
triglycerid
glycogen
week
high
fat
diet
determin
alter
storag
form
fat
glucos
could
contribut
increas
heart
weight
dysfunct
heart
fig
compar
control
feed
heart
increas
cardiac
triglycerid
level
fig
howev
heart
significantli
differ
triglycerid
level
compar
wildtyp
week
high
fat
diet
feed
liver
skelet
muscl
week
high
fat
diet
feed
similarli
significantli
differ
wildtyp
control
fig
heart
dietari
control
chow
significantli
decreas
cardiac
glycogen
compar
wildtyp
heart
fig
heart
accumul
significantli
increas
glycogen
week
high
fat
diet
increas
liver
skelet
muscl
accumul
reach
signific
fig
togeth
studi
illustr
heart
abl
store
fat
triglycerid
alter
glycogen
storag
capac
steadi
state
baselin
condit
high
fat
diet
challeng
akt
glycogen
synthas
kinas
gsk
report
decreas
diabet
cardiomyopathi
along
increas
fibrosi
inflamm
recent
studi
demonstr
role
ppar
activ
develop
adipos
weight
gain
model
diabet
one
studi
treatment
rosiglitazon
mous
model
diabet
shown
promot
increas
cardiac
size
enhanc
fat
volum
similarli
rosiglitazon
side
effect
patient
reveal
increas
fat
gain
baselin
mice
compar
fat
lean
bodi
mass
wildtyp
control
fig
howev
develop
insulin
resist
mice
demonstr
significantli
fat
mass
week
high
fat
diet
chang
lean
bodi
mass
fig
specif
mechan
rosiglitazon
regul
fat
mass
complet
clear
enhanc
ppar
activ
seen
mice
may
one
contribut
factor
accumul
fat
mass
cardiac
function
significantli
wors
wildtyp
mice
challeng
parallel
high
fat
diet
posttransl
modif
intracellular
protein
olink
nacetylglucosamin
oglcnac
diabet
result
excess
glucos
drive
reaction
oglcnac
concert
ubiquitin
mediat
sever
aspect
diabet
cardiomyopathi
oglcnac
modifi
protein
impair
cardiomyocyt
calcium
cycl
via
direct
effect
phospholamban
oglcnacyl
also
blunt
autophagi
regul
express
stimul
cardiac
fibroblast
collagen
synthesi
mediat
cardiac
dysfunct
therefor
measur
amount
oglcnac
protein
heart
hypothes
loss
clear
fewer
oglcnacmodifi
protein
mediat
enhanc
cardiomyopathi
seen
vivo
immunoblot
analysi
oglcnacmodifi
protein
heart
demonstr
differ
wildtyp
heart
mice
fed
chow
diet
week
high
fat
diet
addit
file
figur
modest
increas
oglcnac
level
identifi
week
high
fat
diet
expect
observ
hyperglycemia
differ
oglcnac
could
appear
contribut
exagger
cardiac
dysfunct
sinc
signal
defect
insulin
signal
jnk
signal
alter
autophagi
implic
pathogenesi
diabet
cardiomyopathi
next
determin
heart
alter
process
may
explain
sever
phenotyp
week
high
fat
diet
heart
exhibit
enhanc
activ
determin
western
blot
decreas
signal
determin
western
blot
altern
jnk
signal
determin
pcjun
addit
file
figur
similarli
measur
cardiac
autophagi
heart
high
fat
diet
differ
wildtyp
control
includ
autophagi
flux
protein
ratio
postbafilomycin
treatment
western
blot
protein
level
western
blot
addit
file
figur
studi
demonstr
sever
phenotyp
due
alter
insulin
jnk
signal
reduct
autophagi
report
result
sever
diabet
cardiomyopathi
evid
varieti
cell
cultur
studi
implic
ubiquitin
posttransl
modifi
ppar
transcript
factor
coreceptorscoactiv
liver
lung
fibroblast
adipocyt
macrophag
recent
review
studi
found
ubiquitinmedi
inhibit
ppar
isoform
liganddepend
ligand
requir
ubiquitin
andor
degrad
occur
ratio
ubiquitin
ligas
eg
determin
activ
eg
ratio
inhibit
eg
sinc
consider
evid
show
heart
enhanc
pparact
suggest
endogen
cardiac
inhibit
ppar
activ
nuclear
pprebind
fig
pparregul
gene
express
fig
next
focus
musclespecif
ubiquitin
ligas
might
exert
inhibitori
effect
base
current
knowledg
ubiquitin
regul
ppar
cancer
cell
like
ubiquitin
ligas
interact
number
protein
substrat
notabl
redundantli
interact
roponini
tni
tnt
myosin
light
chain
tcap
telethonin
yeast
twohybrid
studi
unlik
shown
degrad
substrat
recent
review
critic
regul
microtubul
intermedi
filament
sarcomer
mline
stabil
striat
muscl
develop
regul
activ
understand
high
fat
diet
induc
express
next
identifi
isoform
restrict
adipocyt
fig
interestingli
steadi
state
condit
cardiac
protein
level
mice
differ
compar
wildtyp
control
howev
level
slightli
significantli
increas
baselin
fig
far
right
challeng
ppar
ligand
free
fatti
acid
high
fat
diet
week
differ
cardiac
identifi
immunoblot
analysi
signific
increas
protein
express
identifi
fig
taken
togeth
studi
illustr
steadi
state
level
cardiac
isoform
affect
presenc
increas
fig
high
fat
diet
challeng
moreov
result
suggest
chang
activ
could
due
one
multipl
noncanon
posttransl
modif
ubiquitin
eg
monoubiquitin
associ
proteasom
depend
degrad
regul
without
abl
ubiquitin
directli
fig
unclear
mechan
would
indirect
includ
possibl
target
inhibit
yet
determin
ubiquitin
ligas
normal
degrad
exampl
cancer
cell
ubiquitin
degrad
ligand
depend
manner
identif
ubiquitin
ligas
target
known
time
ubiquitin
ligas
degrad
isoform
eg
report
adipocyt
convers
ubiquitin
could
enhanc
deubiquitinas
dub
prevent
proteasomemedi
degrad
unidentifi
next
sought
determin
underli
mechan
endogen
exert
inhibit
pparregul
gene
fig
base
limit
work
perform
ppar
ubiquitin
recent
review
hypothes
ratio
substrat
may
regul
whether
protein
degrad
proteasomedepend
manner
previous
report
cancer
ratio
increas
ratio
result
dosedepend
decreas
steadi
state
protein
level
consist
polyubiquitin
subsequ
degrad
fig
determin
role
proteasom
process
next
repeat
experi
found
decreas
could
prevent
ad
proteasom
inhibitor
fig
sinc
previou
studi
report
ubiquitin
ligas
mediat
proteasom
degrad
ppar
ligand
depend
recent
review
next
repeat
studi
presenc
absenc
ligand
rosiglitazon
demonstr
dosedepend
degrad
ligand
depend
fig
establish
interact
perform
immunoprecipit
studi
cotransfect
cell
lack
ubiquitin
ligas
region
fig
immunoprecipit
identifi
bound
immunoblot
fig
unexpectedli
bind
parallel
studi
suggest
ring
finger
domain
structur
import
interact
vivo
cardiac
protein
level
increas
wild
type
mice
fig
steadi
state
level
either
increas
unchang
wildtyp
mice
respons
week
high
fat
diet
compar
chowf
wildtyp
control
fig
evid
cardiac
affect
steadi
state
isoform
protein
level
yet
inhibit
activ
vivo
heart
enhanc
activ
next
test
may
inhibit
mechanist
specif
want
determin
physiolog
relev
degrad
level
vivo
appear
relev
context
diabet
cardiomyopathi
experiment
studi
indic
high
ratio
result
liganddepend
proteasom
degrad
may
relev
f
g
lane
ub
ppar
full
reaction
unless
otherwis
indic
immunoblot
illustr
autoubiquitin
activ
present
reaction
monoubiquitin
polyubiquitin
valu
express
mean
se
three
independ
experi
oneway
anova
perform
determin
signific
follow
holmsidak
pairwis
comparison
determin
signific
group
p
p
diseas
process
level
increas
vivo
howev
diseas
process
describ
date
therefor
focus
studi
ubiquitin
ppar
isoform
use
ratio
fig
wherea
appear
add
polyubiquitin
lead
degrad
drove
multimonoubiquitin
specif
dimonoubiquitin
ad
four
ubiquitin
moieti
fig
g
respect
howev
unexpectedli
modifi
ubiquitin
vitro
studi
add
perspect
initi
find
endogen
cardiac
greatest
regul
heart
exhibit
activ
found
sibl
wildtyp
heart
fig
far
right
endogen
similarli
next
inhibit
heart
exhibit
activ
found
sibl
wildtyp
heart
fig
far
left
quit
surpris
find
ubiquitin
fig
despit
heart
exhibit
activ
wildtyp
control
fig
middl
gain
insight
may
inhibit
transcript
activ
ubiquitin
next
perform
nuclear
local
studi
use
confoc
microscopi
fig
control
cell
found
could
found
nucleu
cytosol
cell
primarili
nuclear
local
fig
increas
ratio
transfect
interestingli
result
increas
perinuclear
local
fig
notabl
coloc
perinuclear
region
fig
parallel
studi
use
without
ubiquitin
ligas
activ
abrog
perinuclear
target
coloc
fig
sinc
demonstr
bound
fig
studi
indic
regul
locat
may
lie
ubiquitin
ligas
activ
andor
structur
role
requir
interact
sinc
ring
finger
domain
requir
bind
fig
taken
togeth
studi
suggest
target
ubiquitinmedi
regul
activ
alter
local
within
nucleu
parallel
recent
studi
demonstr
autophag
sequestr
receptor
endoplasm
reticulum
nucleu
nontarget
metabolom
analysi
heart
signific
decreas
taurin
myoinositol
four
metabolit
involv
malateaspart
shuttl
urea
malic
acid
phosphor
acid
present
studi
similarli
analyz
heart
use
nontarget
metabolom
analysi
week
high
fat
diet
fig
princip
compon
analysi
pca
fig
well
partial
least
squar
discrimin
analysi
plsda
variabl
interdepend
paramet
vip
analysi
fig
among
annot
metabolit
fig
vip
signific
analyt
detect
taurin
sucros
glycer
acid
pantothen
acid
glutam
acid
among
other
fig
enrich
analysi
identifi
urea
cycl
aspart
metabol
taurin
hypotaurin
metabol
highest
fold
enrich
metabolit
set
fig
base
locat
mitochondria
peroxisom
lysosom
enrich
fig
pathway
analysi
identifi
taurin
hypotaurin
metabol
glycin
serin
threonin
metabol
glutam
metabol
pathway
significantli
affect
test
vip
signific
metabolit
analyz
addit
file
figur
present
studi
demonstr
role
muscl
specif
ubiquitin
ligas
regul
ppar
transcript
factor
context
diabet
clinic
implic
find
broader
recent
studi
identifi
reduct
patient
diabet
ischem
heart
failur
geo
id
http
wwwncbinlmnihgovgeoprofil
rare
mutat
patient
famili
hypertroph
cardiomyopathi
also
identifi
associ
greater
lv
wall
thick
without
mutat
genom
wide
identif
sarscov
suscept
loci
use
collabor
cross
identifi
suscept
factor
sar
infect
includ
evid
mice
suscept
rs
baric
person
commun
geo
access
http
www
ncbinlmnihgovgeoqueryacccgi
taken
togeth
studi
suggest
role
increas
suscept
diseas
given
grow
evid
ppar
antiinflammatori
activ
competit
inhibit
cjuncfo
experiment
recent
review
lockyer
et
al
possibl
reduc
ablat
patient
may
increas
suscept
infect
addit
diabet
demonstr
present
studi
dynam
regul
ppar
transcript
factor
activ
reflect
complex
found
routin
biolog
ppar
famili
transcript
factor
routin
partner
rxr
regul
transcript
target
gene
cofactor
enhanc
ppar
activ
induc
exercis
mitochondri
biogenesi
nuclear
receptor
corepressor
antagon
activ
recent
review
fan
evan
ppar
activ
also
regul
ligand
bind
ligand
bind
domain
includ
endogen
free
fatti
acid
eicosinoid
environment
compound
addit
variou
cocomplex
partner
regul
ppar
transcript
factor
compet
ppar
regul
activ
notabl
make
enhanc
ppar
activ
antiinflammatori
state
top
complex
posttransl
modif
ubiquitin
sumo
report
primarili
cancer
cell
recent
group
cardiomyocyt
first
time
recent
review
topic
ubiquitin
ligas
describ
ubiquitin
proteasomedepend
degrad
ppar
well
sumoyl
report
primarili
nonphysiolog
cultur
condit
report
first
ubiquitin
ligas
regul
ubiquitin
physiolog
process
cardiac
pathophysiolog
process
diabet
add
detail
dimens
regul
begun
understand
layer
complex
appar
present
studi
initi
studi
reveal
heart
enhanc
promin
activ
measur
bind
ppre
dna
fig
howev
enhanc
activ
clearli
due
increas
total
protein
level
fig
similarli
multimonoubiquitin
mechan
explain
inhibit
fig
g
ubiquitin
fig
like
previou
studi
laboratori
nuclear
local
murf
protein
posttransl
ubiquitin
may
regul
process
fig
howev
indirect
regul
protein
level
enhanc
heart
complex
increas
protein
level
transcript
regul
addit
file
figur
lead
hypothesi
regul
complex
posttransl
mechan
describ
eg
degrad
target
enhanc
dub
target
similarli
complex
may
lie
regul
mrna
level
enhanc
heart
throughout
studi
fig
regulatori
element
promot
region
ppar
includ
activ
may
inhibit
protein
clear
mice
equival
protein
fig
mrna
addit
file
figur
howev
heart
also
highli
activ
activ
sever
measur
fig
indic
strong
posttransl
multimonoubiquitin
vitro
fig
may
primari
mechan
regul
vivo
previous
shown
regul
two
nuclear
transcript
factor
found
myocyt
parallel
role
regul
nuclear
ppar
isoform
present
studi
initi
studi
investig
role
differenti
myocyt
identifi
bind
critic
signal
region
giant
protein
titin
via
titin
kinas
region
interact
regul
activ
local
nuclear
transcript
factor
srf
howev
cardiac
appear
regul
srf
activ
vivo
stimul
known
srf
activ
pressur
overloadinduc
cardiac
hypertrophi
suggest
regul
diseas
context
specif
subsequ
implic
redundantli
regul
nuclear
transcript
factor
implic
development
physiolog
hypertrophi
case
evid
degrad
identifi
consist
degradationindepend
regul
ppar
isoform
present
studi
commonli
report
regul
ppar
isoform
cancer
literatur
identifi
posttransl
modif
ubiquitin
sumo
appear
regul
ppar
commonli
inhibit
regul
posttransl
regul
ppar
ubiquitin
previous
identifi
cancer
cell
howev
ubiquitinregul
ppar
heart
similarli
specif
ubiquitin
ligas
identifi
process
prior
identif
contrast
prior
studi
ubiquitin
ligand
depend
result
ppar
degrad
recent
review
identifi
ratio
determin
degrad
occur
fig
physiolog
relev
nondegrad
fig
result
multimonoubiquitin
ppar
isoform
substrat
fig
g
ubiquitin
ligas
substrat
ratio
effect
ubiquitin
chain
type
studi
extens
cancer
regul
seri
eleg
studi
investig
identifi
low
level
induc
monoubiquitin
nuclear
export
wherea
high
level
promot
polyubiquitin
nuclear
degrad
context
stress
li
et
al
endors
notion
nonstress
cell
regul
monoubiquitin
circumv
extens
invest
energi
polyubiquitin
degrad
requir
conceptu
increas
energi
expenditur
may
worthwhil
stress
consid
bigger
degrad
respons
lead
apoptosi
wherea
monoubiquitn
studi
also
highlight
highli
dynam
process
transcript
factor
regul
posttransl
level
subsequ
studi
identifi
sumoyl
process
parallel
ubiquitin
regul
strength
interact
particip
nuclear
export
process
appear
involv
stepwis
interplay
sumoyl
ubiquitin
much
like
three
ppar
isoform
sumoyl
ubiquitin
futur
studi
investig
possibl
role
ppar
isoform
ubiquitin
may
take
consider
requir
sumoyl
ubiquitin
occur
may
also
explain
appar
regul
activ
fig
middl
frame
vivo
absenc
ubiquitin
vitro
fig
demonstr
activ
lack
sumo
andor
interact
protein
anoth
unexpect
find
present
studi
multimonoubiquitin
protein
identifi
vitro
ubiquitin
assay
fig
g
respect
cancer
cell
ubiquitin
ligas
report
diubiquitin
manner
inhibit
anoth
substrat
like
previou
report
multiubiquitin
eg
monoand
diubiquitin
substrat
dior
triubiquitin
ppar
lead
degrad
physiolog
condit
interestingli
induc
sumoyl
target
substrat
includ
npm
addit
ubiquitin
protein
multiubiquitin
may
offer
addit
clue
complex
regul
cardiac
ppar
isoform
previous
unknown
previous
identifi
heart
exhibit
alter
taurin
aspart
acid
dmalic
acid
vivo
compar
strainmatch
wildtyp
heart
present
studi
expand
find
heart
week
high
fat
diet
illustr
differ
taurin
sucros
glycer
acid
pantothen
acid
glutam
acid
fig
altern
taurin
hypotaurin
metabolit
set
fig
heart
interest
given
emerg
role
taurin
chronic
heart
failur
taurin
abund
amino
acid
influenc
heart
respons
stress
one
abund
amino
acid
left
ventricl
act
osmoregul
trigger
osmot
precondit
process
activ
aktdepend
cytoprotect
signal
loss
taurin
depress
protein
synthesi
reduc
energi
reserv
cardiac
surgeri
found
preserv
specif
taurin
shown
attenu
oxid
stress
allevi
heart
failur
diabet
rate
supplement
taurin
patient
heart
failur
use
clinic
understand
cardiac
taurin
biolog
limit
regul
taurin
taurin
na
symport
believ
play
import
function
role
heart
failur
replac
emerg
practic
japan
role
diabet
cardiomyopathi
particular
found
reduc
age
oxid
ldl
scaveng
malondialdehyd
hypochlor
acid
downstream
hclodepend
reduct
least
three
ubiquitin
ligas
name
describ
regul
autophagi
compon
noncardiovascular
system
grow
appreci
regul
autophagi
interact
autophagyrel
protein
cardiac
myofibril
assembl
turnov
surpris
cardiac
autophagi
affect
differenti
high
fat
diet
challeng
addit
file
figur
despit
provoc
parallel
previou
studi
regul
autophag
flux
describ
present
studi
lack
endogen
affect
autophag
flux
high
fat
diet
challeng
addit
file
figur
similarli
steadi
state
cardiac
protein
level
unaffect
lack
endogen
addit
file
figur
indic
cardiac
may
role
cardiac
autophagi
murf
famili
protein
describ
multipl
process
function
redund
compens
model
emerg
evid
autophagi
play
role
pathogenesi
diabet
cardiomyopathi
clear
posttransl
modifi
protein
advanc
glycat
end
product
sever
diseas
target
autophagi
may
offer
one
therapeut
pathway
present
studi
identifi
endogen
protect
via
pathway
howev
host
chang
describ
diabet
cardiomyopathi
character
cardiac
hypertrophi
inflamm
fibrosi
apoptosi
due
alter
insulin
signal
calcium
handl
murf
famili
ubiquitin
ligas
includ
shown
critic
regul
cardiomyocyt
growth
atrophi
specif
physiolog
patholog
growth
attribut
heart
skelet
muscl
regul
cardiac
skelet
muscl
atrophi
chang
seen
diabet
cardiomyopathi
vast
includ
altern
metabol
structur
protein
signal
transduct
ion
channel
crucial
role
enhanc
ppar
signal
central
pathogenesi
diseas
downstream
alter
insulin
resist
regul
ppar
activ
includ
posttransl
modificationmedi
regul
process
littl
understood
cell
type
includ
cardiomyocyt
find
current
studi
implic
first
cardiac
specif
ubiquitin
ligas
function
regul
ppar
isoform
signal
ubiquitin
inhibit
central
pathway
pathogenesi
diseas
sinc
regul
ppar
dynam
cours
diabet
cardiomyopathi
studi
identifi
role
pathogenesi
diabet
cardiomyopathi
regul
ppar
isoform
includ
posttransl
inhibit
cardioprotect
vivo
describ
first
mechan
ubiquitin
ligas
inhibit
multipl
cardiac
ppar
isoform
protect
high
fat
dietinduc
diabet
cardiomyopathi
identifi
protein
level
increas
develop
diabet
cardiomyopathi
induc
high
fat
diet
compar
litterm
wildtyp
heart
heart
exhibit
exagger
diabet
cardiomyopathi
character
earli
onset
systol
dysfunct
larger
left
ventricular
mass
higher
heart
weight
heart
significantli
increas
gene
express
rtqpcr
consist
regul
transcript
factor
vivo
recent
studi
describ
mutat
contribut
sever
famili
hypertroph
cardiomyopathi
present
studi
suggest
lack
activ
found
patient
result
exagger
diabet
cardiomyopathi
present
studi
also
identifi
first
ubiquitin
ligas
regul
cardiac
activ
vivo
via
posttransl
modif
without
degrad
may
repres
novel
potenti
therapeut
target
heart
failur
diabet
